Evolution of the Average Target: Stem, Inc.

Evolution of the Average Target - Stem, Inc.

Evolution of the Target Price: Stem, Inc.

Evolution of the Target Price - Stem, Inc.

Changes in Analyst Recommendations: Stem, Inc.

440a1d95a058.qzLZKdpJiUckt26hNe1WBQSPvgUzUUh_hLsoNdZaik8.6Vm0Q-0a2gtR7l2YQpUTUFe99mprAg4VsvRfVJ8oug3hUYh9tmTlM2vTVg~6e286661b32d91108e5679501d835242
09-25 Stem Shares Rise After UBS Upgrade MT
09-25 UBS Upgrades Stem to Buy From Neutral, Price Target is $7 MT
08-14 UBS Adjusts Price Target on Stem to $7 From $10.50, Keeps Neutral Rating MT
05-11 UBS Cuts Price Target on Stem to $10.50 From $12, Maintains Neutral Rating MT
03-10 UBS Adjusts Price Target on Stem to $12 From $18, Maintains Neutral Rating MT
31/10/25 UBS Adjusts Price Target on Stem Inc to $18 From $16, Maintains Neutral Rating MT
22/08/25 UBS Adjusts Stem Price Target to $16 From $8.60, Maintains Neutral Rating MT
14/04/25 UBS Downgrades Stem to Neutral From Buy, Cuts Price Target to $0.40 From $0.65 MT
07/03/25 UBS Adjusts Stem Price Target to $0.65 From $0.60, Maintains Buy Rating MT
08/11/24 UBS Trims Price Target on Stem to $0.60 From $1, Maintains Buy Rating MT
09/08/24 Susquehanna Downgrades Stem to Neutral From Positive, Adjusts Price Target to $0.50 From $2 MT
08/08/24 UBS Adjusts Price Target on Stem to $1 From $2.50, Maintains Buy Rating MT
07/08/24 TD Cowen Downgrades Stem to Hold From Buy, Adjusts PT to $1 From $4 MT
15/07/24 Susquehanna Trims Price Target on Stem to $2 From $2.50, Maintains Positive Rating MT
08/05/24 UBS Adjusts Price Target on Stem to $2.50 From $5, Maintains Buy Rating MT
11/04/24 Piper Sandler Trims Price Target on Stem to $2 From $3, Maintains Neutral Rating MT
23/03/24 Stem Shares Decline Following Downgrade From Goldman Sachs MT
22/03/24 Goldman Sachs Downgrades Stem to Neutral From Buy, Cuts Price Target to $2.50 From $5.50 MT
29/02/24 Susquehanna Trims Price Target on Stem to $4 From $5.50, Maintains Positive Rating MT
08/12/23 Morgan Stanley Cuts Price Target on Stem to $4 From $7, Maintains Equal-Weight Rating MT
03/11/23 Guggenheim Downgrades Stem to Neutral From Buy MT
01/11/23 Roth MKM Adjusts Price Target on Stem to $3.70 From $6, Maintains Neutral Rating MT
24/10/23 Barclays Trims Stem's Price Target to $5 From $6, Maintains Equalweight Rating MT
20/10/23 BNP Paribas Exane Initiates Stem With Neutral Rating, Price Target is $5 MT
17/10/23 Morgan Stanley Trims Price Target on STEM to $7 From $8, Keeps Equalweight Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- +107.64%
+63.14%
+16.92%
+95.3%
+59.12%
+93.56%
+29.24%
+67.46%
+112.37%
+57.85%
Average +70.26%
Weighted average by Cap. +62.77%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
3.010USD
Average target price
6.250USD
Spread / Average Target
+107.64%
High Price Target
8.000USD
Spread / Highest target
+165.78%
Low Price Target
4.500USD
Spread / Lowest Target
+49.50%

Analyst Consensus Detail

Analyst consensus - Stem, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Stem, Inc.
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
MarketScreener Ratings - Stem, Inc.
  1. Stock Market
  2. Stocks
  3. STEM Stock
  4. Consensus Stem, Inc.